Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1561, 2006-01, pp. : 7-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
INNOVATEive omalizumab therapy effective in difficult-to-treat asthma
Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. :
Rituximab benefits difficult-to-treat patients with RA
Inpharma, Vol. 1, Iss. 1523, 2006-01 ,pp. :
Difficult-to-Treat Gouty Arthritis: A Disease Warranting Better Management
Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. :
Ixabepilone delivers in ER− and HER2+ breast cancer
Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. :
Ixabepilone stacks up in metastatic breast cancer
Inpharma, Vol. 1, Iss. 1595, 2007-01 ,pp. :